| 1 | 554655 | [Aspects of the decrease of some enzyme activities in erythrocytes of subjects with beta-thalassemia]. | Boll Soc Ital Biol Sper | 1979 Apr 30 |
1 |
| 2 | 623919 | [The determination of the red cell isoenzymes 6-phosphogluconate dehydrogenase (E.C.1.1.1.44) and acid phosphatase (E.C.3.1.3.2) by means of agarosegel thinlayer electrophoresis (author's transl)]. | Blut | 1978 Jan 20 |
1 |
| 3 | 1666816 | Clinical utility of fractionating erythrocytes into "Percoll" density gradients. | Adv Exp Med Biol | 1991 |
2 |
| 4 | 1870419 | Triiodothyronine (T3)-associated upregulation and downregulation of nuclear T3 binding in the human fibroblast cell (MRC-5)--stimulation of malic enzyme, glucose-6-phosphate-dehydrogenase, and 6-phosphogluconate-dehydrogenase by insulin, but not by T3. | Metabolism | 1991 Jul |
6 |
| 5 | 2394215 | Analysis of 6-phosphogluconate dehydrogenase isozymes by polyacrylamide gel isoelectric focusing. | Electrophoresis | 1990 Jun |
3 |
| 6 | 3770750 | Polymorphism of 6-PGD in South Korea: a new genetic variant 6-PGD Korea. | Hum Genet | 1986 Oct |
1 |
| 7 | 4024601 | [Erythrocyte enzymes in chronic kidney failure]. | Vutr Boles | 1985 |
3 |
| 8 | 4647721 | Comments on the determination of isoenzyme polymorphism (ADA, AK, 6-PGD, PGM) by cellulose acetate electrophoresis. | Humangenetik | 1972 |
1 |
| 9 | 6234985 | Inhibition of 6-phosphogluconate dehydrogenase by glucose 1,6-diphosphate in human normal and malignant colon extracts. | Cancer Lett | 1984 Jun |
7 |
| 10 | 6860590 | Inhibition of the pentose phosphate shunt by 2,3-diphosphoglycerate in erythrocyte pyruvate kinase deficiency. | Br J Haematol | 1983 Jul |
7 |
| 11 | 7082864 | Separate detection of glucose-6-phosphate dehydrogenase from 6-phosphogluconate dehydrogenase by DEAE-paper chromatography. | Blut | 1982 Jul |
3 |
| 12 | 7107799 | Automated purification of human erythrocytic 6-phosphogluconate dehydrogenase. | J Chromatogr | 1982 Jul 2 |
6 |
| 13 | 7639506 | Inactivation and cleavage of liver 6-P-gluconate dehydrogenase during irradiation in the presence of vanadate. | Arch Biochem Biophys | 1995 Aug 1 |
1 |
| 14 | 7737089 | Electrophoretic conditions for high resolution citrus isozymes in polyacrylamide gel electrophoresis. | Electrophoresis | 1995 Jan |
1 |
| 15 | 15553090 | Functional constraints of 6-phosphogluconate dehydrogenase (6-PGD) based on sequence and structural information. | J Mol Evol | 2004 Sep |
6 |
| 16 | 15624330 | [Study on red cell enzymes and isoenzymes in patients with leukemia and myelodysplastic syndromes]. | Zhonghua Xue Ye Xue Za Zhi | 1997 Jul |
1 |
| 17 | 21188075 | Enzymatic and mRNA Transcript Response of Ovine 6-Phosphogluconate Dehydrogenase (6PGD) in Respect to Different Milk Yield. | Biochem Res Int | 2010 |
3 |
| 18 | 22677172 | Glycolytic cancer cells lacking 6-phosphogluconate dehydrogenase metabolize glucose to induce senescence. | FEBS Lett | 2012 Jul 30 |
5 |
| 19 | 24018234 | One-step purification of soluble recombinant human 6-phosphogluconate dehydrogenase from Escherichia coli. | Protein Expr Purif | 2013 Nov |
5 |
| 20 | 25042803 | Lysine acetylation activates 6-phosphogluconate dehydrogenase to promote tumor growth. | Mol Cell | 2014 Aug 21 |
9 |
| 21 | 25130191 | Investigation of the effects of some phenolic compounds on the activities of glucose-6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase from human erythrocytes. | J Biochem Mol Toxicol | 2014 Nov |
3 |
| 22 | 27270429 | Targeting 6-phosphogluconate dehydrogenase in the oxidative PPP sensitizes leukemia cells to antimalarial agent dihydroartemisinin. | Oncogene | 2017 Jan 12 |
3 |
| 23 | 28713273 | Inhibition of 6-phosphogluconate Dehydrogenase Reverses Cisplatin Resistance in Ovarian and Lung Cancer. | Front Pharmacol | 2017 |
11 |
| 24 | 28848047 | Evidence for a direct cross-talk between malic enzyme and the pentose phosphate pathway via structural interactions. | J Biol Chem | 2017 Oct 13 |
5 |
| 25 | 28978059 | Acute myeloid leukemia cells require 6-phosphogluconate dehydrogenase for cell growth and NADPH-dependent metabolic reprogramming. | Oncotarget | 2017 Sep 15 |
8 |
| 26 | 29340974 | Inhibiting 6-phosphogluconate dehydrogenase selectively targets breast cancer through AMPK activation. | Clin Transl Oncol | 2018 Sep |
2 |
| 27 | 29534964 | Inhibiting 6-phosphogluconate dehydrogenase reverses doxorubicin resistance in anaplastic thyroid cancer via inhibiting NADPH-dependent metabolic reprogramming. | Biochem Biophys Res Commun | 2018 Apr 15 |
13 |
| 28 | 30625329 | Functional Genomics Reveals Synthetic Lethality between Phosphogluconate Dehydrogenase and Oxidative Phosphorylation. | Cell Rep | 2019 Jan 8 |
2 |
| 29 | 30824700 | Tyrosine phosphorylation activates 6-phosphogluconate dehydrogenase and promotes tumor growth and radiation resistance. | Nat Commun | 2019 Mar 1 |
15 |
| 30 | 30841449 | 6PGD inhibition sensitizes hepatocellular carcinoma to chemotherapy via AMPK activation and metabolic reprogramming. | Biomed Pharmacother | 2019 Mar |
5 |
| 31 | 31557707 | Inhibition effects of some antidepressant drugs on pentose phosphate pathway enzymes. | Environ Toxicol Pharmacol | 2019 Nov |
15 |
| 32 | 31586547 | γ-6-Phosphogluconolactone, a Byproduct of the Oxidative Pentose Phosphate Pathway, Contributes to AMPK Activation through Inhibition of PP2A. | Mol Cell | 2019 Dec 19 |
2 |
| 33 | 31848848 | Di(2-ethylhexyl) phthalate inhibits glutathione regeneration and dehydrogenases of the pentose phosphate pathway on human colon carcinoma cells. | Cell Stress Chaperones | 2020 Jan |
4 |
| 34 | 32336239 | The positive feedback loop between Nrf2 and phosphogluconate dehydrogenase stimulates proliferation and clonogenicity of human hepatoma cells. | Free Radic Res | 2020 Dec |
1 |
| 35 | 32719331 | HIF-1α regulates cellular metabolism, and Imatinib resistance by targeting phosphogluconate dehydrogenase in gastrointestinal stromal tumors. | Cell Death Dis | 2020 Jul 27 |
1 |
| 36 | 32792504 | Pancreatic cancers suppress negative feedback of glucose transport to reprogram chromatin for metastasis. | Nat Commun | 2020 Aug 13 |
6 |
| 37 | 32801914 | Discovery of Ebselen as an Inhibitor of 6PGD for Suppressing Tumor Growth. | Cancer Manag Res | 2020 |
8 |
| 38 | 32829780 | 6PGD Upregulation is Associated with Chemo- and Immuno-Resistance of Renal Cell Carcinoma via AMPK Signaling-Dependent NADPH-Mediated Metabolic Reprograming. | Am J Med Sci | 2020 Sep |
6 |
| 39 | 33438819 | The effect of brimonidine and proparacaine on metabolic enzymes: Glucose-6-phosphate dehydrogenase, 6-phosphogluconate dehydrogenase, and glutathione reductase. | Biotechnol Appl Biochem | 2022 Feb |
4 |
| 40 | 33498665 | Oxidative Pentose Phosphate Pathway Enzyme 6-Phosphogluconate Dehydrogenase Plays a Key Role in Breast Cancer Metabolism. | Biology (Basel) | 2021 Jan 23 |
3 |
| 41 | 33817181 | 1-Hydroxy-8-methoxy-anthraquinon Reverses Cisplatin Resistance by Inhibiting 6PGD in Cancer Cells. | Open Life Sci | 2019 Jan |
11 |
| 42 | 34382934 | A feedback loop between the androgen receptor and 6-phosphogluoconate dehydrogenase (6PGD) drives prostate cancer growth. | Elife | 2021 Aug 12 |
1 |
| 43 | 34765544 | Oncogenic Integration of Nucleotide Metabolism <i>via</i> Fatty Acid Synthase in Non-Hodgkin Lymphoma. | Front Oncol | 2021 |
6 |
| 44 | 35075686 | Methyl benzoate derivatives as inhibitors of pentose phosphate pathway, which promotes cancer progression and drug resistance: An in silico study supported by in vitro results. | Biotechnol Appl Biochem | 2022 Jan 24 |
3 |